Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multi-Strategy Anesthesia Intervention for Obese Patients
NCT05016076Withdrawn
- Sponsor
- YingHsuanTai
- Start
- May 2022
- Primary completion
- Aug 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexamethasone in postoperative nausea and vomiting (PONV) (4 arms), sponsored by YingHsuanTai. Primary endpoints: Incidence of postoperative nausea and vomiting at 24 hours, Threshold inspiratory pressure for gastric insufflation and 2 more. Planned start May 2022; status: withdrawn.
02
Drugs
dexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT05016076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05016076.